151 related articles for article (PubMed ID: 19070229)
1. PET/CT in radiation oncology.
Pan T; Mawlawi O
Med Phys; 2008 Nov; 35(11):4955-66. PubMed ID: 19070229
[TBL] [Abstract][Full Text] [Related]
2. PET/CT: form and function.
Blodgett TM; Meltzer CC; Townsend DW
Radiology; 2007 Feb; 242(2):360-85. PubMed ID: 17255408
[TBL] [Abstract][Full Text] [Related]
3. Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners.
Shekhar R; Walimbe V; Raja S; Zagrodsky V; Kanvinde M; Wu G; Bybel B
J Nucl Med; 2005 Sep; 46(9):1488-96. PubMed ID: 16157532
[TBL] [Abstract][Full Text] [Related]
4. Image-guided cancer therapy using PET/CT.
Yap JT; Carney JP; Hall NC; Townsend DW
Cancer J; 2004; 10(4):221-33. PubMed ID: 15383203
[TBL] [Abstract][Full Text] [Related]
5. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
6. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.
Czernin J; Benz MR; Allen-Auerbach MS
Eur J Radiol; 2010 Mar; 73(3):470-80. PubMed ID: 20097498
[TBL] [Abstract][Full Text] [Related]
7. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response.
Heron DE; Andrade RS; Beriwal S; Smith RP
Am J Clin Oncol; 2008 Aug; 31(4):352-62. PubMed ID: 18845994
[TBL] [Abstract][Full Text] [Related]
8. Best practices: consensus on performing positron emission tomography-computed tomography for radiation therapy planning and for therapy response assessment.
Blodgett T
Semin Ultrasound CT MR; 2010 Dec; 31(6):506-15. PubMed ID: 21147378
[TBL] [Abstract][Full Text] [Related]
9. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomography.
Townsend DW
Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
[TBL] [Abstract][Full Text] [Related]
11. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
12. Selecting a new PET/CT system.
Madsen MT
J Am Coll Radiol; 2004 May; 1(5):356-8. PubMed ID: 17411602
[No Abstract] [Full Text] [Related]
13. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
14. Technical aspects of positron emission tomography/computed tomography fusion planning.
Brunetti J; Caggiano A; Rosenbluth B; Vialotti C
Semin Nucl Med; 2008 Mar; 38(2):129-36. PubMed ID: 18243848
[TBL] [Abstract][Full Text] [Related]
15. Multimodality imaging: an update on PET/CT technology.
Mawlawi O; Townsend DW
Eur J Nucl Med Mol Imaging; 2009 Mar; 36 Suppl 1():S15-29. PubMed ID: 19104808
[TBL] [Abstract][Full Text] [Related]
16. Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning.
Frank SJ; Chao KS; Schwartz DL; Weber RS; Apisarnthanarax S; Macapinlac HA
Nat Clin Pract Oncol; 2005 Oct; 2(10):526-33. PubMed ID: 16205772
[TBL] [Abstract][Full Text] [Related]
17. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
18. Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology.
Veit P; Ruehm S; Kuehl H; Stergar H; Mueller S; Bockisch A; Antoch G
Eur J Radiol; 2006 Jun; 58(3):383-9. PubMed ID: 16476533
[TBL] [Abstract][Full Text] [Related]
19. Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer.
Mac Manus MP
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):510-20. PubMed ID: 20927018
[TBL] [Abstract][Full Text] [Related]
20. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
